Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. embryon

EMBRYON

EMBRYON - Develop and commercialize a highly innovative diagnostic-imaging product, improving success rates in the Assisted Reproduction IVF sector

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 EMBRYON project word cloud

Explore the words cloud of the EMBRYON project. It provides you a very rough idea of what is the project "EMBRYON" about.

switzerland    15    stressful    nearly    ph1    publish    generation    billion    identification    introduces    vitro    observations    transferred    2020    approximate    therapy    org    forecasts    1200    extension    ethical    sales    leaving    social    image    births    ll    finalize    100    simpler    deep    italy    fda    procedure    gross    couples    10    scan    rate    morphological    innovation    heavy    patented    predictors    ph2    dollars    favoring    global    units    market    acs    million    precision    double    reactivity    deeper    favored    1400    handcrafted    automated    easier    infertility    clinics    ce    issue    validation    fertilization    instruments    leader    utero    six    ongoing    prototype    overcoming    costly    scientists    20    clearance    validated    proprietary    trials    compliant    microscope    last    improves    embryos    optimization    amongst    reproductive    cheaper    newco    ivf    pregnancy    nikon    big    subjective    outcomes    safer    partnership    cycles    cycle    ww    patients    certify    patterns    merges    smarter    45    solutions    physician    software    innovations    despite    diagnostic    patents    2013    lifetime    specialists    images    shape    embryon    embryo    imaging    revenues    invasive    microscopy    rates    algorithms    clinical    plan    commercial    lab    regulation   

Project "EMBRYON" data sheet

The following table provides information about the project.

Coordinator		 ADVANCED COMPUTER SYSTEMS A.C.S. SPA 

Organization address
address: VIA DELLA BUFALOTTA 378
city: ROMA
postcode: 139
website: www.acsys.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website http://www.unbimbo.it/en/index.html
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-03-01   to  2015-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ADVANCED COMPUTER SYSTEMS A.C.S. SPA IT (ROMA) coordinator 50˙000.00

Map

 Project objective

Infertility is a heavy social issue,experienced by nearly one in six couples during reproductive lifetime. In Vitro Fertilization (IVF) is growing 8-10% p.a.,to 1.5 million therapy cycles and 7.5 billion dollars in 2013. Despite stressful and costly procedures,IVF success rate is low (15-20% births/cycle),leaving big opportunities for innovation and process optimization. EMBRYON introduces to IVF clinics and specialists a last-generation diagnostic-imaging system,favoring better outcomes through deeper,smarter analysis of clinical images. It merges tailored image-processing software and algorithms,patented by ACS,with a high-end commercial IVF microscope.A prototype is under validation with top clinics in Italy and Switzerland,supported by Nikon Instruments (global leader in IVF microscopy). EMBRYON improves the key success factor of any IVF procedure:the identification of 1-2 embryos with best “pregnancy potential” to be transferred in utero,amongst 5-10 generated in vitro. EMBRYON’s precision is double than current handcrafted approaches,favoring higher success rates. It is safer (100% not invasive),thus simpler to certify and adopt,fully compliant with ethical regulation,easier to use (no change to lab procedures) and cheaper than similar products. Key innovations 1. Automated deep scan of embryo shape,overcoming today’s subjective and approximate observations carried by the physician 2. Proprietary algorithms for the measurement of complex morphological patterns,strong predictors of potential Sales forecasts are 1200-1400 units (40-45 M€ gross revenues) by 2020 in Europe and US,favored by: - High reactivity of the IVF sector (scientists/patients) to validated solutions improving outcomes - Commercial partnership with a global IVF microscopy leader In Ph1 we’ll finalize and publish the ongoing clinical studies and make a deep market analysis for Europe-US In Ph2 we plan CE/FDA clearance,WW extension of patents,3 trials in Europe-US,set-up of newco and sales org

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EMBRYON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EMBRYON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

HELP (2019)

Collaboration for innovation: Establishment of a pan-nematode drug development platform

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More